These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6153835)

  • 1. Ranking of glucocorticoid creams and ointments.
    Poulsen J; Rorsman H
    Acta Derm Venereol; 1980; 60(1):57-62. PubMed ID: 6153835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potency ranking of two new topical corticosteroid creams containing 0.1% desonide or 0.05% halometasone utilising the human skin blanching assay.
    Meyer E; Smith EW; Haigh JM; Kanfer I
    Arzneimittelforschung; 1988 Dec; 38(12):1840-3. PubMed ID: 3245859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of topical corticosteroid activity using the vasoconstriction assay in healthy volunteers.
    Görne RC; Greif C; Metzner U; Wigger-Alberti W; Elsner P
    Skin Pharmacol Physiol; 2007; 20(3):133-40. PubMed ID: 17191036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The same glucocorticoid in brand-name products. Does increasing the concentration result in greater topical biologic activity?
    Stoughton RB; Wullich K
    Arch Dermatol; 1989 Nov; 125(11):1509-11. PubMed ID: 2817915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of patients' satisfaction in using potent topical corticosteroid preparations.
    Shibata Y; Ikeda H; Kihira K
    Hiroshima J Med Sci; 2007 Dec; 56(3-4):33-9. PubMed ID: 18516932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative bio-availability and activity of proprietary topical corticosteroid preparations: vasoconstrictor assays on thirty-one ointments.
    Barry BW; Woodford R
    Br J Dermatol; 1975 Nov; 93(5):563-71. PubMed ID: 1203181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of activity of different topical corticosteroid creams and ointments using a vasoconstriction assay: superiority of hydrocortisone butyrate over hydrocortisone].
    Korting HC; Maslen K; Gross G; Willers C
    J Dtsch Dermatol Ges; 2005 May; 3(5):348-53. PubMed ID: 16372801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antiinflammatory effect of a topical corticosteroid: known brand versus generic drug].
    Castanedo-Cázares JP; Quistián-Galván J; Torres-Alvarez B; Torres-Ruvalcaba A; Moncada B
    Gac Med Mex; 2001; 137(4):311-4. PubMed ID: 11519354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proprietary hydrocortisone creams. Vasoconstrictor activities and bio-availabilities of six preparations.
    Barry BW; Woodford R
    Br J Dermatol; 1976 Oct; 95(4):423-5. PubMed ID: 974028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative skin blanching assay of corticosteroid creams using tristimulus colour analysis.
    Chan SY; Li Wan Po A
    J Pharm Pharmacol; 1992 May; 44(5):371-8. PubMed ID: 1359050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of techniques to assess skin blanching following the topical application of glucocorticoids.
    Noon JP; Evans CE; Haynes WG; Webb DJ; Walker BR
    Br J Dermatol; 1996 May; 134(5):837-42. PubMed ID: 8736322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
    Ling M; Gottlieb A; Pariser D; Caro I; Stewart D; Scott G; Abrams K
    J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing the formulation of semisolid preparations with special reference to corticosteroid products.
    Worthington HE
    Acta Derm Venereol Suppl (Stockh); 1973; 53():29-34. PubMed ID: 4518660
    [No Abstract]   [Full Text] [Related]  

  • 14. A double-blinded randomized trial testing the tolerability and efficacy of a novel topical agent with and without occlusion for the treatment of cellulite: a study and review of the literature.
    Rao J; Paabo KE; Goldman MP
    J Drugs Dermatol; 2004; 3(4):417-25. PubMed ID: 15303786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical drug classification.
    Buhse L; Kolinski R; Westenberger B; Wokovich A; Spencer J; Chen CW; Turujman S; Gautam-Basak M; Kang GJ; Kibbe A; Heintzelman B; Wolfgang E
    Int J Pharm; 2005 May; 295(1-2):101-12. PubMed ID: 15847995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double-blind placebo-controlled trial.
    Tosti A; Iorizzo M; Botta GL; Milani M
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1243-7. PubMed ID: 17062039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eumovate (clobetasone butyrate) 0.05% cream with its moisturizing emollient base has better healing properties than hydrocortisone 1% cream: a study in nickel-induced contact dermatitis.
    Parneix-Spake A; Goustas P; Green R
    J Dermatolog Treat; 2001 Dec; 12(4):191-7. PubMed ID: 12241627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of in vivo bioequivalence methodology for dermatologic corticosteroids based on pharmacodynamic modeling.
    Singh GJ; Adams WP; Lesko LJ; Shah VP; Molzon JA; Williams RL; Pershing LK
    Clin Pharmacol Ther; 1999 Oct; 66(4):346-57. PubMed ID: 10546918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of skin stripping, in vitro release, and skin blanching response methods to measure dose response and similarity of triamcinolone acetonide cream strengths from two manufactured sources.
    Pershing LK; Bakhtian S; Poncelet CE; Corlett JL; Shah VP
    J Pharm Sci; 2002 May; 91(5):1312-23. PubMed ID: 11977107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of different desoximetasone preparations compared to other topical corticosteroids in the vasoconstriction assay.
    Borelli C; Gassmueller J; Fluhr JW; Nietsch KH; Schinzel S; Korting HC
    Skin Pharmacol Physiol; 2008; 21(3):181-7. PubMed ID: 18523415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.